AC Immune SA

ACIU
As of the close on Sep 25, 2026
Price
$2.52
Market cap
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
P/E (diluted TTM)
—
The last four quarters are not all on file
EPS (TTM)
—
The last four quarters are not all on file
Dividend yield
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How AC Immune SA Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: AC Immune SA — 20-F filed Mar 13, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 11 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
EFG International AG 2026-03-31 9,900 $27.2K SEC filing
China Universal Asset Management Co., Ltd. 2026-03-31 17,852 $49.1K SEC filing
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2026-03-31 89,262 $245K SEC filing
GEODE CAPITAL MANAGEMENT, LLC 2026-03-31 63,601 $175K SEC filing
RENAISSANCE TECHNOLOGIES LLC 2026-03-31 624,367 $1.72M SEC filing
ACADIAN ASSET MANAGEMENT LLC 2026-03-31 96,907 Not shown SEC filing
XTX Topco Ltd 2026-03-31 14,304 $39.3K SEC filing
MARSHALL WACE, LLP 2026-03-31 131,458 $362K SEC filing
Activest Wealth Management 2026-03-31 1,000 $2.75K SEC filing
GF FUND MANAGEMENT CO. LTD. 2026-03-31 2,242 $6.17K SEC filing
BVF INC/IL 2026-03-31 19,822,436 $54.5M SEC filing
MILLENNIUM MANAGEMENT LLC 2026-03-31 792,657 $2.18M SEC filing
GSA CAPITAL PARTNERS LLP 2026-03-31 11,530 Not shown SEC filing
Mirae Asset Global Investments Co., Ltd. 2026-03-31 5,247 $14.4K SEC filing
Forum Finance Group S.A. 2026-03-31 2,000 Not shown SEC filing
TWO SIGMA INVESTMENTS, LP 2026-03-31 39,091 $108K SEC filing
BNP PARIBAS FINANCIAL MARKETS 2026-03-31 2,410 $6.63K SEC filing
Quinn Opportunity Partners LLC 2026-03-31 10,100 $27.8K SEC filing
Dauntless Investment Group, LLC 2026-03-31 107,489 $296K SEC filing
Strengthening Families & Communities, LLC 2026-03-31 200 $550 SEC filing
  • Each value is checked against AC Immune SA's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at AC Immune SA's share price.

Filer report history

Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.

  • JPMORGAN CHASE & CO: 8,721 shares reported 2025-12-31; 7,640 shares reported 2026-03-31.
  • UBS Group AG: 194,349 shares reported 2025-12-31; 101,629 shares reported 2026-03-31.
  • DIMENSIONAL FUND ADVISORS LP: 213,464 shares reported 2025-12-31; 390,165 shares reported 2026-03-31.
  • Silverberg Bernstein Capital Management LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
  • WELLS FARGO & COMPANY/MN: 1,006,289 shares reported 2025-12-31; 1,004,284 shares reported 2026-03-31.
  • ROYAL BANK OF CANADA: 858 shares reported 2025-12-31; 860 shares reported 2026-03-31.
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 375,623 shares reported 2025-12-31; 405,658 shares reported 2026-03-31.
  • CITADEL ADVISORS LLC: 71,151 shares reported 2025-12-31; 267,233 shares reported 2026-03-31.
  • SIMPLEX TRADING, LLC: 3,258 shares reported 2025-09-30; 6,620 shares reported 2026-03-31.
  • BlackRock, Inc.: 502,169 shares reported 2025-12-31; 524,278 shares reported 2026-03-31.
  • Tower Research Capital LLC (TRC): 6,166 shares reported 2025-12-31; 7,009 shares reported 2026-03-31.
  • BANK OF AMERICA CORP /DE/: 21,471 shares reported 2025-12-31; 17,437 shares reported 2026-03-31.

Showing the 12 most recent filer reports.

16 filers have only one report here.

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-05-15Pfeifer Andrea · Chief Executive OfficerCommon ShareS — Open market or private sale−10,0002.79SEC filing
2026-04-15Pfeifer Andrea · Chief Executive OfficerShareP — Open market or private purchase−10,0003.14SEC filing
2026-04-15 (amended)Pfeifer Andrea · Chief Executive OfficerShareS — Open market or private sale−10,0003.14SEC filing

Showing 3 of 3 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-11Buetler Monika · DirectorCommon ShareA — Grant, award, or other acquisition+17,751SEC filing
2026-06-11AGUIAR-LUCANDER RENEE · DirectorShare Option (right to buy)A — Grant, award, or other acquisition+38,889SEC filing
2026-06-11June Carl Howard · DirectorCommon ShareA — Grant, award, or other acquisition+16,568SEC filing
2026-06-11AGUIAR-LUCANDER RENEE · DirectorCommon ShareA — Grant, award, or other acquisition+16,568SEC filing
2026-06-11Twyman Roy Ervin · DirectorCommon ShareA — Grant, award, or other acquisition+16,568SEC filing
2026-06-11Zuegel Martin · Interim CEOCommon ShareA — Grant, award, or other acquisition+33,136SEC filing
2026-06-11Buetler Monika · DirectorShare Option (right to buy)A — Grant, award, or other acquisition+41,667SEC filing
2026-06-11Twyman Roy Ervin · DirectorShare Option (right to buy)A — Grant, award, or other acquisition+38,889SEC filing

Showing 8 of 10 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.